Short Interest in Viemed Healthcare, Inc. (NASDAQ:VMD) Expands By 18.4%

Viemed Healthcare, Inc. (NASDAQ:VMD - Get Free Report) saw a significant growth in short interest in October. As of October 31st, there was short interest totalling 361,200 shares, a growth of 18.4% from the October 15th total of 305,100 shares. Based on an average daily trading volume, of 155,500 shares, the days-to-cover ratio is currently 2.3 days. Currently, 1.1% of the company's shares are sold short.

Insider Buying and Selling at Viemed Healthcare

In other Viemed Healthcare news, Director Nitin Kaushal sold 30,000 shares of the business's stock in a transaction on Monday, November 11th. The stock was sold at an average price of $9.56, for a total value of $286,800.00. Following the transaction, the director now owns 126,843 shares of the company's stock, valued at approximately $1,212,619.08. The trade was a 19.13 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Randy E. Dobbs sold 36,261 shares of Viemed Healthcare stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total value of $336,502.08. Following the completion of the sale, the director now owns 107,706 shares of the company's stock, valued at approximately $999,511.68. The trade was a 25.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 20.00% of the company's stock.

Institutional Trading of Viemed Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in VMD. Vanguard Group Inc. increased its stake in shares of Viemed Healthcare by 53.0% in the first quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company's stock valued at $16,803,000 after buying an additional 617,009 shares during the period. Apis Capital Advisors LLC increased its position in Viemed Healthcare by 193.0% in the 2nd quarter. Apis Capital Advisors LLC now owns 234,400 shares of the company's stock valued at $1,535,000 after acquiring an additional 154,400 shares during the period. Russell Investments Group Ltd. raised its stake in shares of Viemed Healthcare by 5.3% during the first quarter. Russell Investments Group Ltd. now owns 146,952 shares of the company's stock valued at $1,386,000 after acquiring an additional 7,386 shares during the last quarter. Pinnacle Wealth Planning Services Inc. acquired a new position in shares of Viemed Healthcare during the first quarter worth $135,000. Finally, Price T Rowe Associates Inc. MD bought a new stake in shares of Viemed Healthcare in the first quarter worth $97,000. Institutional investors own 74.24% of the company's stock.

Viemed Healthcare Stock Performance

Shares of NASDAQ VMD traded down $0.14 during mid-day trading on Friday, reaching $8.92. 116,909 shares of the company were exchanged, compared to its average volume of 153,938. The stock has a market capitalization of $347.32 million, a P/E ratio of 33.48 and a beta of 1.43. The company has a quick ratio of 1.19, a current ratio of 1.31 and a debt-to-equity ratio of 0.03. Viemed Healthcare has a twelve month low of $6.21 and a twelve month high of $10.44. The company's 50-day simple moving average is $8.31 and its 200-day simple moving average is $7.53.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.02. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The firm had revenue of $58.00 million for the quarter.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.